Press Release

Adoption of Capsule Endoscopy in Home-Care Settings to Escalate the Global Capsule Endoscopy Market Growth During 2022-2027

The Global Capsule Endoscopy market is projected to grow at a CAGR of 10.42% during the forecast period, 2022-27, says MarkNtel Advisors in their recent research report. This is due to the rising prevalence of gastrointestinal disorders & chronic ailments such as Ulcerative Colitis, Colorectal Cancer, Oesophageal cancer, and Gastrointestinal Bleeding across the globe. According to the WHO, International Agency for Research on Cancer, around 481,552 Oesophageal cancer cases were reported in Asia & 52,993 in Europe, as of 2020. Hence, capsule endoscopy has seen a major increase in popularity due to the fact that it is a less painful & safer operation than other technologies, and it has proven to be an efficient tool for the detection of polyps in screening settings.

Further, due to the supply chain interruption & severe lockdown measures, the COVID-19 epidemic had a detrimental influence on the market. As a result of the postponed & delayed elective surgeries, the number of diagnostic lab procedures associated with cancer & gastrointestinal procedure decreased, affecting the global growth of the capsule endoscopy market. However, the market regained its momentum after the FDA clearance of capsule endoscopy in the home-care settings for emergency use.

Furthermore, the Global Capsule Endoscopy is predicted to have a lucrative growth in the forecast years, owing to the rising patient awareness regarding minimally invasive technologies & growing healthcare infrastructure across various geographies. Additionally, precise & reliable early cancer diagnosis would assist persons in better addressing diseases on a mass scale, resulting in the positive rise of capsule endoscopy in the approaching years.

The Global Capsule Endoscopy market is projected to grow at a CAGR of 10.42% during the forecast period, 2022-27, says MarkNtel Advisors in their recent research report. This is due to the rising prevalence of gastrointestinal disorders & chronic ailments such as Ulcerative Colitis, Colorectal Cancer, Oesophageal cancer, and Gastrointestinal Bleeding across the globe. According to the WHO, International Agency for Research on Cancer, around 481,552 Oesophageal cancer cases were reported in Asia & 52,993 in Europe, as of 2020. Hence, capsule endoscopy has seen a major increase in popularity due to the fact that it is a less painful & safer operation than other technologies, and it has proven to be an efficient tool for the detection of polyps in screening settings.

Further, due to the supply chain interruption & severe lockdown measures, the COVID-19 epidemic had a detrimental influence on the market. As a result of the postponed & delayed elective surgeries, the number of diagnostic lab procedures associated with cancer & gastrointestinal procedure decreased, affecting the global growth of the capsule endoscopy market. However, the market regained its momentum after the FDA clearance of capsule endoscopy in the home-care settings for emergency use.

Furthermore, the Global Capsule Endoscopy is predicted to have a lucrative growth in the forecast years, owing to the rising patient awareness regarding minimally invasive technologies & growing healthcare infrastructure across various geographies. Additionally, precise & reliable early cancer diagnosis would assist persons in better addressing diseases on a mass scale, resulting in the positive rise of capsule endoscopy in the approaching years.